Precise Therapeutic Targeting of Distinct NRXN1+/- Mutations.
Fernando MB, Fan Y, Zhang Y, Kammourh S, Murphy AN, Ghorbani S, Onatzevitch R, Pero A, Padilla C, Flaherty EK, Prytkova IK, Cao L, Williams S, Fang G, Slesinger PA, Brennand KJ.
Fernando MB, et al. Among authors: ghorbani s.
bioRxiv [Preprint]. 2023 Dec 23:2023.10.28.564543. doi: 10.1101/2023.10.28.564543.
bioRxiv. 2023.
PMID: 37961635
Free PMC article.
Preprint.